I would restate that to the "US market is where pharmaceutical companies like recoup their executive officer costs, which makes drugs more expensive in the US than anywhere else. The US subsidizes executive salaries for the rest of the world..." http://www.ibtimes.com/healthcare-pharma-ceos-paid-more-top-...